Keyphrases
Airway Function
100%
Cyclooxygenase-1 (COX-1)
100%
Aspirin-induced Asthma
100%
Cyclooxygenase-2
100%
Aspirin
45%
Airway
18%
Cyclooxygenase-1/2
18%
Cyclooxygenase-2 Inhibitors
18%
Rofecoxib
18%
Bronchi
18%
Immunoreactivity
18%
Bronchoconstriction
18%
Diclofenac
9%
Selective Inhibitor
9%
Genetically Engineered Mice
9%
Human Donor
9%
Asthma
9%
Wild Mice
9%
Naproxen
9%
Airway Cells
9%
Acetylcholine
9%
Airway Hyperresponsiveness
9%
Bronchoconstrictor
9%
Drug Specificity
9%
U46619
9%
Clinical Observation
9%
Clinical Data
9%
Cell Culture
9%
Influence Function
9%
SC-560
9%
Sensitive Individuals
9%
Immunology and Microbiology
Immunoreactivity
100%
Aspirin-Induced Asthma
100%
Wild Type Mouse
50%
Airway Cell
50%
Genetically Engineered Mouse Strain
50%
Drug Specificity
50%
Asthma
50%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
50%
Wild Type
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclooxygenase 1
100%
Cyclooxygenase 2
100%
Aspirin Exacerbated Respiratory Disease
100%
Acetylsalicylic Acid
45%
Prostaglandin Synthase
18%
Bronchoconstriction
18%
Rofecoxib
18%
15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid
9%
COX-2 Inhibitor
9%
Naproxen
9%
Bronchoconstricting Agent
9%
5 (4 Chlorophenyl) 1 (4 Methoxyphenyl) 3 Trifluoromethyl 1h Pyrazole
9%
Asthma
9%
Genetically Engineered Mouse Strain
9%
Diclofenac
9%
Wild Type Mouse
9%
Ibuprofen
9%
Drug Specificity
9%
Acetylcholine
9%
Biochemistry, Genetics and Molecular Biology
Cyclooxygenase
100%
Immunoreactivity
10%
Rofecoxib
10%
Genetically Engineered Mouse Strain
5%
COX-2 Inhibitor
5%
Wild Type Mouse
5%
U46619
5%
Acetylcholine
5%
Drug Specificity
5%
Wild Type
5%